August 6, 2024 C-Path Welcomes New Advisory Members to Alpha-1 Antitrypsin Deficiency Consortium C-Path's Critical Path for Alpha-1 Antitrypsin Deficiency (CPA-1) consortium today announced the addition of several...
July 26, 2024 C-Path’s Alzheimer’s Consortium Unveils Seminal Methodology to Enhance Alzheimer’s Clinical Trials Using Imaging Biomarkers C-Path is proud to announce the publication of a new study in the journal Alzheimer’s & Dementia...
July 23, 2024 DATAcc by DiMe Expands Library of Digital Measurement Products to Include Parkinson’s Disease Today, the Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe), in partnership....
July 23, 2024 C-Path’s Lysosomal Disease Consortium Welcomes Chiesi Group as its Newest Member C-Path's Critical Path for Lysosomal Diseases (CPLD) Consortium today proudly announced the addition of Chiesi Group...
July 1, 2024 Lane United Football Club’s ‘United Against Cancer’ Game to Support Sarcoma Community The event, scheduled for Wed., July 3, is supported by C-Path's CDRC, xCures and hummel as sponsors.
June 20, 2024 C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development C-Path, a leader in forming collaborations that accelerate drug development, and Centogene N.V. (Nasdaq: CNTG)...
June 20, 2024 C-Path Partners with FARA to Fortify RDCA-DAP and Further Accelerate Drug Development with new Friedreich’s Ataxia Data C-Path announced the targeted integration of additional Friedreich’s ataxia...
June 12, 2024 C-Path’s Parkinson’s Consortium Supports Groundbreaking Research Utilizing Smartwatches to Monitor Disease Progression Critical Path Institute (C-Path) today announced a new publication on how the use of wearable technology...
June 12, 2024 C-Path’s AI Collaborations Accelerate Drug Development, Improve Lives Critical Path Institute (C-Path) today announced the publication of a new peer-reviewed paper in the journal Clinical and...
May 15, 2024 NEW FUNDING OPPORTUNITY! C-Path’s TRxA Announces its First Biologics-focused RFP for Academic Investigators C-Path Translational Therapeutics Accelerator (TRxA) today announced its inaugural biologics-focused Request for Proposals (RFP)..